• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

J&J sues Amgen over plan to sell drug similar to Stelara

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 01, 2022 at 10:52: AM
via Johnson & Johnson’s Janssen unit has sued Amgen Inc. over its plan to market a drug for ulcerative colitis and other conditions similar to J&J's top-selling Stelara, saying it would infringe on two patents.

article source
 

<



Similar threads

cafead
J&amp;J sues company over alleged abuse of its cost assistance program
Replies
0
Views
138
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Former J&amp;J VP sues pharma giant, accusing top execs of discriminating, harassing and...
Replies
0
Views
259
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Baltimore sues J&amp;J for spinning up a &#039;sham&#039; Zytiga patent to fend off generics
Replies
0
Views
164
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson unit sues ex-rep over defection to Zimmer Biomet
Replies
0
Views
196
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Surgeon sues J&amp;J’s DePuy in royalties dispute
Replies
0
Views
165
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote